GSK Will Shutter Reliant Offices

BERNARDS TWP., NJ-The UK-based GlaxoSmithKline acquired locally based Reliant Pharmaceuticals this past November in a $1.65-billion deal, and now that deal is putting a major block of office space back on the market. GSK officials have revealed plans to shut down Reliant’s headquarters, totaling 96,000 sf at 110 Allen Rd. in this township’s Liberty Corner section.

The news became public after GSK filed papers with the NJ Department of Labor indicating that it would ax more than 100 staffers within the next 60 days, mostly in marketing, compliance, payroll and business analysis. Some 50 staffers will remain on-site temporarily as the local operations gradually shut down. A GSK spokesman could not be reached for comment.